What levonorgestrel‑releasing intrauterine devices (LNG‑IUDs) are available for a 49‑year‑old woman with irregular menstrual bleeding who needs bleeding control and contraception?

Examples of Levonorgestrel-Releasing Intrauterine Devices (LNG-IUDs)

For a 49-year-old woman needing both bleeding control and contraception, the available LNG-IUD options include devices releasing 52 mg, 19.5 mg, and 13.5 mg of levonorgestrel, with the 52 mg system being the optimal choice for managing irregular bleeding while providing contraception.

Available LNG-IUD Systems

The currently available LNG-IUDs differ in their hormone content, duration of effectiveness, and specific indications 1:

52 mg LNG-IUS (High-Dose)

• Duration: 5 years of contraceptive protection (possibly up to 7-8 years) 1
• Daily release: 20 mcg levonorgestrel
• FDA-approved indications:
  • Contraception
  • Treatment of heavy menstrual bleeding 2
  • Endometrial protection during hormone replacement therapy 3
• Best for: Women with heavy menstrual bleeding, adenomyosis, fibroids, or those needing endometrial protection during estrogen therapy 1

19.5 mg LNG-IUS (Mid-Dose)

• Duration: 5 years of contraceptive protection 4
• Daily release: 12 mcg levonorgestrel
• Features: Smaller frame (3.8 mm inserter), lower amenorrhea rates than 52 mg system 4
• Best for: Women wanting longer protection than the 13.5 mg system but with a smaller device 1

13.5 mg LNG-IUS (Low-Dose)

• Duration: 3 years of contraceptive protection 1
• Features: Smallest frame with 3.8 mm one-handed inserter 1
• Best for: Nulliparous women or those preferring a smaller device 1

Recommendation for Your Patient

For a 49-year-old woman with irregular menstrual bleeding requiring both bleeding control and contraception, the 52 mg LNG-IUS is the definitive choice 1, 5. Here's why:

Clinical Reasoning:

1. Dual benefit: This is the only LNG-IUD with FDA approval specifically for treating heavy menstrual bleeding while providing contraception 2

2. Perimenopausal advantages: At age 49, she's likely perimenopausal, and the 52 mg system offers:

   • Superior bleeding control through endometrial suppression 6
   • Potential for amenorrhea (which eliminates bleeding problems) 7
   • Endometrial protection if she later needs estrogen therapy 3
   • Contraception through the perimenopausal transition 6

3. Efficacy for bleeding: The 52 mg system significantly improves bleeding-related quality of life, with effects comparable to surgical options like endometrial ablation 5, 7

4. Duration: Five years of protection will likely carry her through to menopause 1

Important Caveats

• Bleeding management: While the CDC guidelines note "no interventions identified" for managing irregular bleeding in LNG-IUD users 8, this refers to treatment of breakthrough bleeding once the device is in place, not the device's therapeutic effect on pre-existing heavy bleeding

• Not for emergency contraception: Despite recent discussions, LNG-IUDs should not be used for emergency contraception—only copper IUDs are established for this purpose 9

• Age consideration: Younger women with severe dysmenorrhea have higher discontinuation rates, but this is less relevant for a 49-year-old 7